IP6K Inhibitors

ES3084523T3Undetermined Publication Date: 2026-11-13TAKEDA PHARMA CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
ES2018723386T
Authority / Receiving Office
ES · ES
Patent Type
Patents
Current Assignee / Owner
Priority Date
2017-03-30
Filing Date
2018-03-29
Publication Date
2026-11-13
Estimated Expiration
2038-03-29

Smart Images

  • Figure 00000041_0000
    Figure 00000041_0000
  • Figure 00000042_0000
    Figure 00000042_0000
  • Figure 00000043_0000
    Figure 00000043_0000
Patent Text Reader

Abstract

The present invention aims to provide a heterocyclic compound with IP6K inhibitory action, which is expected to be useful as a prophylactic or therapeutic agent for diseases such as heart failure, diabetes, and other similar conditions. A compound represented by formula (I): where each symbol is defined in the SPECIFICATION, or a salt thereof, has IP6K inhibitory action and is expected to be useful as a prophylactic or therapeutic agent for diseases such as heart failure, diabetes, and other similar conditions.
Need to check novelty before this filing date? Find Prior Art